Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 83.65 CHF 1.09% Market Closed
Market Cap: CHf4.2B

EV/GP

4.2
Current
0%
Cheaper
vs 3-y average of 4.2

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
4.2
=
Enterprise Value
CHf5.3B
/
Gross Profit
CHf1.2B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
4.2
=
Enterprise Value
CHf5.3B
/
Gross Profit
CHf1.2B

Valuation Scenarios

Galenica AG is trading below its 3-year average

If EV/GP returns to its 3-Year Average (4.2), the stock would be worth CHf83.89 (0% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-2%
Maximum Upside
+41%
Average Upside
14%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 4.2 CHf83.65
0%
3-Year Average 4.2 CHf83.89
+0%
5-Year Average 4.1 CHf81.76
-2%
Industry Average 5.9 CHf117.76
+41%
Country Average 4.9 CHf97.53
+17%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

In line with most companies in Switzerland
Percentile
46th
Based on 878 companies
46th percentile
4.2
Low
0 — 2.5
Typical Range
2.5 — 8.3
High
8.3 —
Distribution Statistics
Switzerland
Min 0
30th Percentile 2.5
Median 4.9
70th Percentile 8.3
Max 378.3

Galenica AG
Glance View

Market Cap
4.2B CHF
Industry
Health Care

In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.

GALE Intrinsic Value
99.27 CHF
Undervaluation 16%
Intrinsic Value
Price CHf83.65
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett